Key substrates are phosphorylated by PKA, which are involved in insulin synthesis and secretion [31]
This testing identifies whether a patient is better suited for semaglutide, tirzepatide (a dual GLP-1/GIP receptor agonist), or a combination approachall without cardiovascular risk
However, whether their combined use enhances weight loss remains unclear
Targeted by Retatrutide and other weight loss medications, producing appetite suppression and metabolic benefits
Vera is fantastic with the IV therapies, always providing top-notch care
You may benefit from a clinical assessment if you: Experience ongoing tiredness or low energy Follow a vegetarian or vegan diet Experience brain fog, poor concentration, or memory issues Have been advised you may be at risk of deficiency Take medicines or have conditions that may affect absorption (your prescriber will review this) Those with dietary risk factors, absorption issues, or a history of low B12 may be more likely to benefit however, suitability is confirmed during consultation